Ian F. Cameron
Chief Executive Officer at MicroPharm Ltd.
Profile
Ian F.
Cameron is currently the Chief Executive Officer at MicroPharm Ltd.
Prior to this, he worked as an Investment Director at SMH Venture Finance Ltd.
from 2002 to 2022.
He also served as a Non-Executive Director at Domainex Ltd.
and held Principal positions at Babcock International Group Plc, BII Group Ltd., and Unilever UK Ltd.
Mr. Cameron received his undergraduate degree from the University of Leeds and his MBA from Bradford University School of Management.
Ian F. Cameron active positions
| Companies | Position | Start |
|---|---|---|
MicroPharm Ltd.
 MicroPharm Ltd. Pharmaceuticals: MajorHealth Technology MicroPharm Ltd. develops and manufactures polyclonal therapeutics. The British company was founded in 1998 by John Landon. The CEO is Ian F. Cameron. | Chief Executive Officer | - |
Former positions of Ian F. Cameron
| Companies | Position | End |
|---|---|---|
SMH Venture Finance Ltd.
 SMH Venture Finance Ltd. Investment ManagersFinance SMH Venture Finance Ltd (SMH Venture Finance) is a venture capital subsidiary of YFM Equity Partners Ltd founded in 1999. The firm is headquartered in Leeds, Yorkshire. | Private Equity Investor | 14/06/2022 |
BII Group Ltd.
 BII Group Ltd. Investment ManagersFinance BII Group Ltd. (BII Group) is a private equity/venture capital, a subsidiary of Government of United Kingdom was founded by James Murray Grant in 1948. The firm is headquartered in London with offices in Bengaluru, Mumbai, Nairobi, Pakistan, Sandton, and Bangladesh. | Corporate Officer/Principal | - |
| BABCOCK INTERNATIONAL GROUP PLC | Corporate Officer/Principal | - |
Unilever UK Ltd.
 Unilever UK Ltd. Food: Major DiversifiedConsumer Non-Durables Unilever UK Ltd. manufactures, markets and distributes packaged consumer goods. The firm offers products in the areas of foods, home care and personal care. The company is headquartered in Leatherhead, the United Kingdom. | Corporate Officer/Principal | - |
Domainex Ltd.
 Domainex Ltd. Pharmaceuticals: MajorHealth Technology Domainex Ltd. operates as a drug discovery company. Its services include drug target expression, structural biology, virtual hit screening, medicinal chemistry, computational chemistry, assay development, and fragment based screening. The firm offers combinatorial domain hunting technology, and leadbuilder virtual hit screening software. The company was founded by Laurence Harris Pearl, Renos Savva, Paul Driscoll and Chrisostosmos Prodromou in 2001 and is headquartered in Saffron Walden, the United Kingdom. | Director/Board Member | - |
Training of Ian F. Cameron
| University of Leeds | Undergraduate Degree |
| Bradford University School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BABCOCK INTERNATIONAL GROUP PLC | Producer Manufacturing |
| Private companies | 5 |
|---|---|
BII Group Ltd.
BII Group Ltd. Investment ManagersFinance BII Group Ltd. (BII Group) is a private equity/venture capital, a subsidiary of Government of United Kingdom was founded by James Murray Grant in 1948. The firm is headquartered in London with offices in Bengaluru, Mumbai, Nairobi, Pakistan, Sandton, and Bangladesh. | Finance |
SMH Venture Finance Ltd.
SMH Venture Finance Ltd. Investment ManagersFinance SMH Venture Finance Ltd (SMH Venture Finance) is a venture capital subsidiary of YFM Equity Partners Ltd founded in 1999. The firm is headquartered in Leeds, Yorkshire. | Finance |
Unilever UK Ltd.
Unilever UK Ltd. Food: Major DiversifiedConsumer Non-Durables Unilever UK Ltd. manufactures, markets and distributes packaged consumer goods. The firm offers products in the areas of foods, home care and personal care. The company is headquartered in Leatherhead, the United Kingdom. | Consumer Non-Durables |
Domainex Ltd.
Domainex Ltd. Pharmaceuticals: MajorHealth Technology Domainex Ltd. operates as a drug discovery company. Its services include drug target expression, structural biology, virtual hit screening, medicinal chemistry, computational chemistry, assay development, and fragment based screening. The firm offers combinatorial domain hunting technology, and leadbuilder virtual hit screening software. The company was founded by Laurence Harris Pearl, Renos Savva, Paul Driscoll and Chrisostosmos Prodromou in 2001 and is headquartered in Saffron Walden, the United Kingdom. | Health Technology |
MicroPharm Ltd.
MicroPharm Ltd. Pharmaceuticals: MajorHealth Technology MicroPharm Ltd. develops and manufactures polyclonal therapeutics. The British company was founded in 1998 by John Landon. The CEO is Ian F. Cameron. | Health Technology |
- Stock Market
- Insiders
- Ian F. Cameron
